What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
Guido Reifenberger mainly focuses on Cancer research, Pathology, Glioma, DNA methylation and Internal medicine.
His work deals with themes such as Mutation, Gene, Molecular biology, Tumor suppressor gene and Comparative genomic hybridization, which intersect with Cancer research.
Guido Reifenberger has researched Pathology in several fields, including Anaplastic astrocytoma, Astrocytoma and Cell culture.
His biological study focuses on Diffuse Astrocytoma.
The study incorporates disciplines such as Bioinformatics, Biomarker, Epigenetics, Methyltransferase and Candidate gene in addition to DNA methylation.
His biological study spans a wide range of topics, including Surgery and Oncology.
His most cited work include:
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. (6125 citations)
- International network of cancer genome projects (1611 citations)
- The WHO Classification of Tumors of the Nervous System (1559 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Cancer research, Glioma, Pathology, Internal medicine and DNA methylation.
His research on Cancer research also deals with topics like
- Molecular biology that intertwine with fields like Comparative genomic hybridization,
- Loss of heterozygosity most often made with reference to Tumor suppressor gene.
As a member of one scientific family, he mostly works in the field of Glioma, focusing on IDH1 and, on occasion, Isocitrate dehydrogenase.
His Pathology research includes themes of Molecular genetics and Astrocytoma, Oligodendroglioma.
His Internal medicine research is multidisciplinary, relying on both Glioblastoma, Surgery and Oncology.
His research in DNA methylation intersects with topics in Methylation and Epigenetics.
He most often published in these fields:
- Cancer research (44.33%)
- Glioma (38.03%)
- Pathology (34.66%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (44.33%)
- Glioma (38.03%)
- Internal medicine (18.49%)
In recent papers he was focusing on the following fields of study:
Guido Reifenberger spends much of his time researching Cancer research, Glioma, Internal medicine, Oncology and DNA methylation.
His work deals with themes such as Phenotype, Regulation of gene expression and Gene, which intersect with Cancer research.
His studies in Glioma integrate themes in fields like Isocitrate dehydrogenase and CDKN2A.
His Oncology research integrates issues from Chemotherapy, Proportional hazards model, Recurrent glioblastoma, Glioblastoma and Cohort.
His research integrates issues of Hazard ratio, Methylation, Mutation, IDH1 and Meningioma in his study of DNA methylation.
His Pathology study integrates concerns from other disciplines, such as Tumor progression and Frameshift mutation.
Between 2018 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- Longitudinal molecular trajectories of diffuse glioma in adults (92 citations)
- cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. (87 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
His primary areas of investigation include Cancer research, Glioma, Temozolomide, Brain tumor and Internal medicine.
Guido Reifenberger interconnects Phenotype, BRAF V600E, Cell cycle, Regulation of gene expression and MYB in the investigation of issues within Cancer research.
His Glioma study incorporates themes from Immunoediting, Somatic hypermutation and IDH1.
Brain tumor is a subfield of Pathology that he investigates.
His Pathology study frequently draws connections to other fields, such as Frameshift mutation.
In his research on the topic of Internal medicine, Chemotherapy, Not Otherwise Specified, Astrocytic glioma, Diffuse Astrocytoma and Glioblastoma is strongly related with Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
